基因组学市场的实验室自动化预计在预测期内(2018 - 2023 年)的复合年增长率为 7.70%。基因组实验室是集成的高通量实验室,专注于遗传学和基因组技术的发展。这些实验室专注于开发使用多种技术平台并最大化研究/临床样本价值的综合策略。基因组分析涉及核酸纯化、扩增、标记和信号检测(特异性反应、分离和信号计数)。在基因组学中实施实验室自动化使实验室能够标准化样品处理和分析。此外,自动化液体处理器的实施降低了样品错位的风险。
实验室自动化工具可为实验室和诊断机构带来长期成本节约。阻碍该市场增长的主要因素是在研究实验室安装这些工具所需的高昂初始成本。这些工具不能孤立地看待,它们包含了高效运营所需的硬件设备、软件解决方案和管理系统。硬件设备成本随自动化程度而变化,而软件成本则取决于实验室进行的操作类型。由于预算有限和对投资回报的需求,许多研究实验室可能无法证明这些高昂的资本成本是合理的。对高资本要求的需求阻碍了增长。
自动化液体处理器已在实验室自动化中得到广泛采用,因为它们通过有效分配死体积大大减少了处理时间并最大限度地减少了样品污染的范围。由于通过使用少量液体显着提高了实验的准确性,对使用传感器集成系统的自动化液体处理的强烈需求有所增加。液体处理在许多应用中发挥着关键作用,例如基因组研究,因为正在分配样品以实现顺畅的工作流程。在现代,自动化液体处理已被证明是各种应用的福音,因为它提高了效率。能够处理微量液体的液体处理器的发展促进了市场上实验室自动化系统的快速发展。
北美市场格局极具活力,并购活动频繁。过去几年,加拿大经济持续增长。由于加拿大经济相对稳定,利润更加明显。随着美国成本的增加,需要一种更便宜且可行的替代方案来提供可持续的长期利益。以更低的成本提高运营效率是推动北美市场的关键因素。
主要参与者: Thermo Fisher Scientific、Beckman Coulter、Hudson Robotics、Becton Dickinson、Synchron Lab Automation、Agilent Technologies、Siemens Healthcare、Tecan Group Ltd、Perkinelmer、Bio-Rad、Roche Holding AG、Eppendorf AG、Shimadzu 和 Aurora Biomed 等其他。
1. Introduction
1.1 Key Deliverables of the Study
1.2 Study Assumptions
1.3 Market Definition
1.4 Key Findings of the Study
2. Research Approach and Methodology
3. Executive Summary
4. Market Overview
4.1 Market Segmentation
4.2 Market Overview
4.3 Industry Value Chain Analysis
4.4 Industry Attractiveness – Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products or Services
4.4.5 Competitive Rivalry among Existing Competitors
5. Market Dynamics
5.1 Introduction
5.2 Factors Driving the Market
5.2.1 Technological Innovations Leading to Device Miniaturization & Increased Throughput
5.2.2 Need For Higher Reproducibility and Effective Management of the Vast Amounts of Data Generated
5.3 Factors Restraining the Market
5.3.1 High Capital Requirements for Setup
5.3.2 Inconsistent Nature of Technological and Process Development
5.3.3 Slower Rate of Adoption in Small and Medium Scale Labs
6. Technology Snapshot
7. Different Equipment In Lab Automation
7.1 Automated Liquid Handlers
7.2 Automated Plate Handlers
7.3 Robotic Arms
7.4 Automated Storage & Retrieval Systems (AS/RS)
8. Global Lab Automation Segmentation
8.1 By Equipment
8.1.1 Automated Liquid Handlers
8.1.2 Automated Plate Handlers
8.1.3 Robotic Arms
8.1.4 Automated Storage & Retrieval Systems (AS/RS)
8.1.5 Software
8.1.5.1 Laboratory Information Management System (LIMS)
8.1.5.2 Laboratory Information System (LIS)
8.1.5.3 Chromatography Data System (CDS)
8.1.5.4 Electronic Lab Notebook (ELN)
8.1.5.5 Scientific Data Management System (SDMS)
8.1.6 Analyzers
8.1.6.1 Biochemistry Analyzers
8.1.6.2 Immuno-Based Analyzers
8.1.6.3 Hematology Analyzers
8.1.6.3.1 Cell Counters
8.1.6.3.2 Coagulometers
8.2 By Field of Application
8.2.1 Drug Discovery
8.2.2 Genomics
8.2.3 Proteomics
8.2.4 Clinical Diagnostics
8.2.5 Others
8.3 By Geography
8.3.1 North America
8.3.2 Europe
8.3.3 Asia-Pacific
8.3.4 Rest of the World
9. Competitive Intelligence – Company Profiles
9.1 Thermo Fisher Scientific
9.2 Danaher
9.3 Hudson Robotics
9.4 Becton Dickinson
9.5 Synchron Lab Automation
9.6 Agilent Technologies
9.7 Siemens Healthcare
9.8 Tecan Group Ltd
9.9 Perkinelmer
9.10 Honeywell International
9.11 Bio-Rad
9.12 Roche Holding AG
9.13 Eppendorf AG
9.14 Shimadzu
9.15 Aurora Biomed
*List not exhaustive
10. Investment Analysis
11. Future Outlook of the Market
12. Disclaimer